34567 879:; ?@ /ab
TRANSCRIPT
pISSN 1229-4292 / eISSN 2508-3619 J Korean Obstet Gynecol. VOL.32
NO.1 : 037-047 (2019)
https://doi.org/10.15204/jkobgy.2019.32.1.037
37
1 , 1
1, 2, 2, 2, 2
ABSTRACT
Analysis of the Characteristics and Treatment of Polycystic Ovary Syndrome Patients in a Korean Medicine Hospital
Seung-Hyeok Park1, Jin-Moo Lee2, Chang-Hoon Lee2, Jun-Bock Jang2, Deok-Sang Hwang2
1Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University 2Dept. of Korean Medicine Gynecology, College of Korean Medicine,
Kyung Hee University
Objectives: The purpose of this study was to analyze the current characteristics and prescriptions of outpatients with Polycystic Ovary Syndrome (PCOS).
Methods: We searched medical records from January 1, 2017 to December 31, 2017 and found out 31 patients who first visited with PCOS.
Results: The average age of PCOS patients was 26.48±5.15 years old, average height was 162.16±5.56 cm, average weight was 55.27±9.34 kg, and average BMI was 21.01±3.48 kg/m2
A total of 24 patients who had received western treatment for PCOS in the past, 13 people received oral contraceptions, 4 hormones, 2 metformin, one hormone and metformin, also 4 people were treated for assisted reproductive technologies due to infertility. There were only two patients who combined Korean and Western treatments.
The most common menstrual-related symptoms of PCOS patients were oligomenorrhea (48.4%) and dysmenorrhea (22.6%). Other symptoms were the highest in the cold symptoms (54.8%), followed by infertility (9.7%).
The average number of patients visiting the hospital was 6.26±7.2, with 22 (71.0%) coming from 1 to 5. The average treatment period for patients was 10.1±10.8 weeks, with 41.9% the largest for 1 to 4 weeks.
Acupuncture (93.5%), moxibustion (96.8%) herbmed (96.8%) was treated to most PCOS patients. The most commonly used herbal medicines were Ongyeong-tang (35.5%), Ijin-tang-gami (19.4%), Dodam-tang-gami (12.9%), and Jogyeongjongok-tang-gami (12.9%).
Conclusions: These results could be helpful to treat PCOS patients in Korean gynecologic clinical fields.
Key Words: Polycystic Ovary Syndrome, PCOS, Characteristics, Treatment
4)
Tel : 02-958-9160 E-mail : [email protected]
38
, , ,
, ,
, , ,
, ,
1).
,
, ,
2). ,
,
3).
,
.
5) 6)
,
7) 8-10), 11,12)
,
13) 2000
.
, 2017
.
. PCOS
Rotterdam Criteria
, , 2
14),
.
861 34 PCOS
,
PCOS
31 .
.
2.
.
, , ,
J Korean Obstet Gynecol Vol.32 No.1 February 2019
39
,
.
.
.
.
26.48±5.15, 20 71%
(Table 1).
55.27±9.34 kg (Table 3)
. BMI 21.01±
3.48 kg/m2(Table 4) .
Age N (%) 15~19 1 (3.2) 20~24 11 (35.5) 25~29 11 (35.5) 30~34 5 (16.1) 35~39 3 (9.7) Total 31 (100)
Mean±SD 26.48±5.15
Table 1. Age Distribution
Height (cm) N (%) 150~154 3 (9.7) 155~159 7 (22.6) 160~164 10 (32.3) 165~169 8 (25.8) 170~ 3 (9.7) Total 31 (100)
Mean±SD 162.16±5.56
Table 2. Height Distribution
Weight (kg) N (%) 40~44 2 (6.5) 45~49 9 (29.0) 50~54 9 (29.0) 55~59 5 (16.1) 60~64 2 (6.5) 65~69 1 (3.2) 70~ 3 (9.7) Total 31 (100)
Mean±SD 55.27±9.34
Table 3. Weight Distribution
BMI (kg/m2) N (%) ~17.9 2 (6.5)
18.0~18.9 3 (9.7) 19.0~19.9 7 (22.6) 20.0~20.9 8 (25.8) 21.0~21.9 3 (9.7) 22.0~22.9 3 (9.7) 23.0~23.9 3 (9.7) 24.0~24.9 1 (3.2) 25.0~ 1 (3.2) Total 31 (100)
Mean±SD 21.01±3.48
Table 4. BMI Distribution
. 13
, 4
, 2
, 3
, 1
2 , 2
40
,
.
3.
(48.4%),
(22.6%) (Table 5).
symptoms N (%)
1 Oligomenorrhea 15 (48.4) 2 Dysmenorrhea 7 (22.6) 3 Hypomenorrhea 3 (9.7) 3 Irregular Menstruation 3 (9.7) 5 Premenstrual Syndrome 2 (6.5) 5 Polymenorrhea 2 (6.5) 5 Hypermenorrhea 2 (6.5) 8 Amenorrhea 1 (3.2) 8 Metrorrhagia 1 (3.2)
Table 5. Menstruation Related Symptoms of PCOS Patients
4.
(54.8%), (9.7%)
(Table 6).
PCOS
. 861 PCOS
(Table 7),
R-3.5.0 Chi-square
test . PCOS
(P=0.1628).
Rank Other symptoms N (%) 1 Cold symptoms 17 (54.8) 2 Infertility 3 (9.7)
3 Pelvic and lower abdomen pain
2 (6.5)
Table 6. Other Symptoms of PCOS Patients
Patients without PCOS
Patients with PCOS
Table 7. Number of Patients with/without PCOS and Cold Symptoms
5.
.
6.26±7.2 ,
1~5 22(71.0%)
(Table 8).
Visit N (%) 1~5 22 (71.0) 6~10 2 (6.5) 11~15 3 (9.7) 16~20 2 (6.5) 21~ 2 (6.5) Total 31 (100)
Mean±SD 6.26±7.2
6.
J Korean Obstet Gynecol Vol.32 No.1 February 2019
41
.
10.1±10.8 , 1~4
41.9% (Table 9).
Duration (weeks) N (%) 1~4 13 (41.9) 5~8 8 (25.8) 9~12 3 (9.7) 13~ 7 (22.6) Total 31 (100)
Mean±SD 10.1±10.8
7.
, (CV6), (CV4),
(CV3) (SP6)
.
Treatment N (%) Acupuncture 29 (93.5) Moxibustion 30 (96.8) Herbmed 30 (96.8)
Table 10. Treatment for PCOS Patients
8.
(35.5%), (19.4%),
, ,
,
, ,
,
.
Rank Herbal medicine N (%) 1 Ongyeong-tang 11 (35.5) 2 Ijin-tang-gami 6 (19.4) 3 Dodam-tang-gami 4 (12.9) 3 Jogyeongjongok-tang-gami 4 (12.9) 5 Tonggyeong-tang 3 (9.7) 5 Samul-tang-gami 3 (9.7) 5 Ikwiseungyang-tang 3 (9.7) 5 Hyangsapyeongwi-san 3 (9.7) 9 Banchong-san 2 (6.5) 9 Gyoaejihyeol-tang 2 (6.5)
Others 6 (19.4)
.
, ,
16), 1990 National
Reproduction and Embryology(ESHRE)
2
14), 2006 Androgen Excess Society(AES)
18).
42
1).
,
.
1
.
861
37.53±11.41 , 31
26.48±5.15 20 71%
.
.
162.16±5.56 cm,
55.27±9.34 kg .
BMI 21.01±3.48 kg/m2
.
, BMI
30 kg/m2
, 25 kg/m2
19).
(48.4%), (22.6%)
. (9.7%),
(54.8%), (9.7%)
, (6.5%),
(6.5%), (3.2%),
(3.2%) .
, ,
, , , ,
,
1),
,
.
, 10.1±10.8
.
1.91±1.712)
,
10 47% 11)
.
8.849),
33.3%, 3 25.3%
10).
20)
.
31 29
, 1
.
, (CV6), (CV4),
. ⋅⋅
,
J Korean Obstet Gynecol Vol.32 No.1 February 2019
43
21).
22).
.
(35.5%), (19.4%),
, , ,
, , Table
, , ,
.
, “
,
,
23). ,
24).
, , ,
,
8 g, 6 g,
⋅() ⋅⋅ 4 g,
⋅() 3 g, ()⋅
2 g, 6 g 1 ,
2 3 .
” 23).
,
,
25).
, , , , ,
,
26).
8 g, ⋅ 4 g, () 2 g,
6 g 1 2
3 .
.
, , ,
,
27).
() 8 g, ()⋅⋅
⋅⋅⋅⋅⋅
4 g 1 ,
2 3 .
“
” 23),
.
44
28).
⋅⋅⋅⋅
4 g, ⋅⋅⋅
⋅⋅⋅⋅⋅
⋅⋅ 3 g, () 1 g
1 2 3
.
.
29), 30), 31),
32) ,
33), 34), 35), 36),
139)
2000 30
13), 2016
20 40) .
,
.
31 26.48±5.15
, 20 71%
. 162.16±5.56 cm
, 55.27±9.34 kg
, BMI 21.01±3.48 kg/m2
.
, 1
, 4
.
3.
48.4%
, 22.6%
. 54.8%
, 9.7%
.
10.1±10.8 .
35.5% ,
19.4%, 12.9%,
12.9% .
Received : Jan 10, 2019
Revised : Jan 11, 2019
Accepted : Feb 22, 2019
45
References
Gynecology. Gynecology. 4th edition.
Seoul:Korea Medical Book Publishing
of Pregnancy Outcomes in Women
with Polycystic Ovary Syndrome. Hum
Prod Update. 2006;12(6):673-83.
Therapy for Polycystic Ovary Syndromes
: Systematic Review. J Korean Obstet
Gynecol. 2014;27(2):71-82.
on Polycystic Ovarian Syndrome. J
Korean Obstet Gynecol. 1997;10(1):
of Outpatients in Oriental Obstetric
& Gynecology Clinic of the Oriental
Hospital for 3 Years. J Korean Obstet
Gynecol. 2011;24(4):163-73.
Complaints of Outpatients Visiting
Seoul. J Korean Obstet Gynecol. 2017;
30(1):29-41.
of 106 Breast Cancer Patients Who
Received Oriental Medical Treatment.
:228-36.
in Female Infertility who Admitted
to Oriental Hospital. J Korean Obstet
Gynecol. 2010;23(3):184-91.
in Female Infertility Patients Admitted
to Korean Medicine Hospital. J Korean
Obstet Gynecol. 2013;26(2):120-37.
of Outpatients in Oriental Obstetric
& Gynecology Clinic of the Oriental
Hospital for 3 Years. J Korean
Obstet Gynecol. 2011;24(4):163-73.
Clinical Analysis of 104 Sanhupung
Patients that visited at an Oriental
Medicine Hospital. J Korean Obstet
Gynecol. 2010;23(3):192-204.
with Postpartum Disease at the Korean
Gynecology Clinic of Traditional Korean
Medicine Hospital. J Korean Obstet
Gynecol. 2018;31(3):61-78.
of Oriental Medicine Treatment for
Polycystic Ovarian Disease. J Korean
Obstet Gynecol. 2000;13(2):437-51.
PCOS Consensus Workshop Group.
Fertil Steril. 2004;81(1):19-25.
http://www.koreantk.com/ktkp2014/
dictionary/dictionary-view.page.
16. Stein IF, Leventhal ML. Amenorrhea
46
29(2):181-91.
Criteria for Polycystic Ovary Syndrome:
Towards a Rational Approach. In
Polycystic Ovary Syndrome. Dunaif
GR, eds. 1st ed. Boston:Blackwell
Scientific. 1992:377-84.
and PCOS Society Criteria for the
Polycystic Ovary Syndrome: The
Steril. 2009;91(2):456-88.
Is There an Asian Phenotype for
Polycystic Ovarian Syndrome? Best
Practice & Research Clinical Obstetrics
Effect of Integrated Medicine for
Polycystic Ovary Syndrome Subfertility
Meta-Analysis. J Korean Obstet
Moxibustion . Gyeonggido:Jipmoondang.
-acupuncture on Sameumgyo(SP-6)·
2003;16(2):76-86.
Donguibogamchulpansa. 2010:300-1,
310-1, 1750-1.
Korean Obstet Gynecol. 1998;11(1)
on Body Weight and Ovarian Reaction
in Obesity Mice. J Korean Obstet
Gynecol. 2003;16(2):68-75.
-tang on the Progression of the
Estradiol Valerate-induced Polycystic
Gynecol. 2010;23(2):1-19.
-tang on the Polycystic Ovaries Induced
by Estradiol Valerate in Rats. J
Korean Obstet Gynecol. 2002;15(2)
-tang on the Maturation of Follicles
and NGF Expression in Rats with
Estradiol Valerate-induced Polycystic
2011;24(2):52-67.
Gigantis Radix on Gene Expression
of Ovarian Tissue in Polycystic Ovary
Syndrome Rats. J Korean Obstet
Gynecol. 2011;24(3):28-47.
Rhizoma on Ovarian Tissue in
Polycystic Ovary Syndrome Rats. J
Korean Obstet Gynecol. 2012;25(2)
Spina on the Polycystic Ovary Induced
J Korean Obstet Gynecol Vol.32 No.1 February 2019
47
Korean Obstet Gynecol. 2010;23(2)
Rhizoma on Relevant Conditions of
Metabolic Syndrome in Rats with
Polycystic Ovary Syndrome. J Korean
Obstet Gynecol. 2011;24(4):20-30.
on the Estradiol Valerate-induced
Obstet Gynecol. 2008;21(3):60-74.
on the Maturation of Follicles and
NGF Expression in Rats with Estradiol
Valerate-induced Polycystic Ovaries.
:27-41.
-tang on the Progression of the
Estradiol Valerate-induced Polycystic
J Korean Obstet Gynecol. 2011;24(3)
:48-72.
-tang on the Estradiol Valerate-induced
Polycystic Ovary in Rats. J Korean
Obstet Gynecol. 2007;20(1):99-113.
-tang on the Estradiol Valerate-
induced Polycystic Ovaries in Rats.
J Korean Obstet Gynecol. 2008;21(2)
:1-16.
Shingihwanhapchangbudodam-tang
Obstet Gynecol. 2007;20(1):84-98.
for the One Case that Diagnosed
Polycystic Ovarian Disease. J Korean
Obstet Gynecol. 2014;27(3):151-7.
of 20 Amenorrhea or Oligomenorrhea
Patients due to Polycystic Ovarian
Syndrome. J Korean Obstet Gynecol.
2016;29(3):47-56.
https://doi.org/10.15204/jkobgy.2019.32.1.037
37
1 , 1
1, 2, 2, 2, 2
ABSTRACT
Analysis of the Characteristics and Treatment of Polycystic Ovary Syndrome Patients in a Korean Medicine Hospital
Seung-Hyeok Park1, Jin-Moo Lee2, Chang-Hoon Lee2, Jun-Bock Jang2, Deok-Sang Hwang2
1Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University 2Dept. of Korean Medicine Gynecology, College of Korean Medicine,
Kyung Hee University
Objectives: The purpose of this study was to analyze the current characteristics and prescriptions of outpatients with Polycystic Ovary Syndrome (PCOS).
Methods: We searched medical records from January 1, 2017 to December 31, 2017 and found out 31 patients who first visited with PCOS.
Results: The average age of PCOS patients was 26.48±5.15 years old, average height was 162.16±5.56 cm, average weight was 55.27±9.34 kg, and average BMI was 21.01±3.48 kg/m2
A total of 24 patients who had received western treatment for PCOS in the past, 13 people received oral contraceptions, 4 hormones, 2 metformin, one hormone and metformin, also 4 people were treated for assisted reproductive technologies due to infertility. There were only two patients who combined Korean and Western treatments.
The most common menstrual-related symptoms of PCOS patients were oligomenorrhea (48.4%) and dysmenorrhea (22.6%). Other symptoms were the highest in the cold symptoms (54.8%), followed by infertility (9.7%).
The average number of patients visiting the hospital was 6.26±7.2, with 22 (71.0%) coming from 1 to 5. The average treatment period for patients was 10.1±10.8 weeks, with 41.9% the largest for 1 to 4 weeks.
Acupuncture (93.5%), moxibustion (96.8%) herbmed (96.8%) was treated to most PCOS patients. The most commonly used herbal medicines were Ongyeong-tang (35.5%), Ijin-tang-gami (19.4%), Dodam-tang-gami (12.9%), and Jogyeongjongok-tang-gami (12.9%).
Conclusions: These results could be helpful to treat PCOS patients in Korean gynecologic clinical fields.
Key Words: Polycystic Ovary Syndrome, PCOS, Characteristics, Treatment
4)
Tel : 02-958-9160 E-mail : [email protected]
38
, , ,
, ,
, , ,
, ,
1).
,
, ,
2). ,
,
3).
,
.
5) 6)
,
7) 8-10), 11,12)
,
13) 2000
.
, 2017
.
. PCOS
Rotterdam Criteria
, , 2
14),
.
861 34 PCOS
,
PCOS
31 .
.
2.
.
, , ,
J Korean Obstet Gynecol Vol.32 No.1 February 2019
39
,
.
.
.
.
26.48±5.15, 20 71%
(Table 1).
55.27±9.34 kg (Table 3)
. BMI 21.01±
3.48 kg/m2(Table 4) .
Age N (%) 15~19 1 (3.2) 20~24 11 (35.5) 25~29 11 (35.5) 30~34 5 (16.1) 35~39 3 (9.7) Total 31 (100)
Mean±SD 26.48±5.15
Table 1. Age Distribution
Height (cm) N (%) 150~154 3 (9.7) 155~159 7 (22.6) 160~164 10 (32.3) 165~169 8 (25.8) 170~ 3 (9.7) Total 31 (100)
Mean±SD 162.16±5.56
Table 2. Height Distribution
Weight (kg) N (%) 40~44 2 (6.5) 45~49 9 (29.0) 50~54 9 (29.0) 55~59 5 (16.1) 60~64 2 (6.5) 65~69 1 (3.2) 70~ 3 (9.7) Total 31 (100)
Mean±SD 55.27±9.34
Table 3. Weight Distribution
BMI (kg/m2) N (%) ~17.9 2 (6.5)
18.0~18.9 3 (9.7) 19.0~19.9 7 (22.6) 20.0~20.9 8 (25.8) 21.0~21.9 3 (9.7) 22.0~22.9 3 (9.7) 23.0~23.9 3 (9.7) 24.0~24.9 1 (3.2) 25.0~ 1 (3.2) Total 31 (100)
Mean±SD 21.01±3.48
Table 4. BMI Distribution
. 13
, 4
, 2
, 3
, 1
2 , 2
40
,
.
3.
(48.4%),
(22.6%) (Table 5).
symptoms N (%)
1 Oligomenorrhea 15 (48.4) 2 Dysmenorrhea 7 (22.6) 3 Hypomenorrhea 3 (9.7) 3 Irregular Menstruation 3 (9.7) 5 Premenstrual Syndrome 2 (6.5) 5 Polymenorrhea 2 (6.5) 5 Hypermenorrhea 2 (6.5) 8 Amenorrhea 1 (3.2) 8 Metrorrhagia 1 (3.2)
Table 5. Menstruation Related Symptoms of PCOS Patients
4.
(54.8%), (9.7%)
(Table 6).
PCOS
. 861 PCOS
(Table 7),
R-3.5.0 Chi-square
test . PCOS
(P=0.1628).
Rank Other symptoms N (%) 1 Cold symptoms 17 (54.8) 2 Infertility 3 (9.7)
3 Pelvic and lower abdomen pain
2 (6.5)
Table 6. Other Symptoms of PCOS Patients
Patients without PCOS
Patients with PCOS
Table 7. Number of Patients with/without PCOS and Cold Symptoms
5.
.
6.26±7.2 ,
1~5 22(71.0%)
(Table 8).
Visit N (%) 1~5 22 (71.0) 6~10 2 (6.5) 11~15 3 (9.7) 16~20 2 (6.5) 21~ 2 (6.5) Total 31 (100)
Mean±SD 6.26±7.2
6.
J Korean Obstet Gynecol Vol.32 No.1 February 2019
41
.
10.1±10.8 , 1~4
41.9% (Table 9).
Duration (weeks) N (%) 1~4 13 (41.9) 5~8 8 (25.8) 9~12 3 (9.7) 13~ 7 (22.6) Total 31 (100)
Mean±SD 10.1±10.8
7.
, (CV6), (CV4),
(CV3) (SP6)
.
Treatment N (%) Acupuncture 29 (93.5) Moxibustion 30 (96.8) Herbmed 30 (96.8)
Table 10. Treatment for PCOS Patients
8.
(35.5%), (19.4%),
, ,
,
, ,
,
.
Rank Herbal medicine N (%) 1 Ongyeong-tang 11 (35.5) 2 Ijin-tang-gami 6 (19.4) 3 Dodam-tang-gami 4 (12.9) 3 Jogyeongjongok-tang-gami 4 (12.9) 5 Tonggyeong-tang 3 (9.7) 5 Samul-tang-gami 3 (9.7) 5 Ikwiseungyang-tang 3 (9.7) 5 Hyangsapyeongwi-san 3 (9.7) 9 Banchong-san 2 (6.5) 9 Gyoaejihyeol-tang 2 (6.5)
Others 6 (19.4)
.
, ,
16), 1990 National
Reproduction and Embryology(ESHRE)
2
14), 2006 Androgen Excess Society(AES)
18).
42
1).
,
.
1
.
861
37.53±11.41 , 31
26.48±5.15 20 71%
.
.
162.16±5.56 cm,
55.27±9.34 kg .
BMI 21.01±3.48 kg/m2
.
, BMI
30 kg/m2
, 25 kg/m2
19).
(48.4%), (22.6%)
. (9.7%),
(54.8%), (9.7%)
, (6.5%),
(6.5%), (3.2%),
(3.2%) .
, ,
, , , ,
,
1),
,
.
, 10.1±10.8
.
1.91±1.712)
,
10 47% 11)
.
8.849),
33.3%, 3 25.3%
10).
20)
.
31 29
, 1
.
, (CV6), (CV4),
. ⋅⋅
,
J Korean Obstet Gynecol Vol.32 No.1 February 2019
43
21).
22).
.
(35.5%), (19.4%),
, , ,
, , Table
, , ,
.
, “
,
,
23). ,
24).
, , ,
,
8 g, 6 g,
⋅() ⋅⋅ 4 g,
⋅() 3 g, ()⋅
2 g, 6 g 1 ,
2 3 .
” 23).
,
,
25).
, , , , ,
,
26).
8 g, ⋅ 4 g, () 2 g,
6 g 1 2
3 .
.
, , ,
,
27).
() 8 g, ()⋅⋅
⋅⋅⋅⋅⋅
4 g 1 ,
2 3 .
“
” 23),
.
44
28).
⋅⋅⋅⋅
4 g, ⋅⋅⋅
⋅⋅⋅⋅⋅
⋅⋅ 3 g, () 1 g
1 2 3
.
.
29), 30), 31),
32) ,
33), 34), 35), 36),
139)
2000 30
13), 2016
20 40) .
,
.
31 26.48±5.15
, 20 71%
. 162.16±5.56 cm
, 55.27±9.34 kg
, BMI 21.01±3.48 kg/m2
.
, 1
, 4
.
3.
48.4%
, 22.6%
. 54.8%
, 9.7%
.
10.1±10.8 .
35.5% ,
19.4%, 12.9%,
12.9% .
Received : Jan 10, 2019
Revised : Jan 11, 2019
Accepted : Feb 22, 2019
45
References
Gynecology. Gynecology. 4th edition.
Seoul:Korea Medical Book Publishing
of Pregnancy Outcomes in Women
with Polycystic Ovary Syndrome. Hum
Prod Update. 2006;12(6):673-83.
Therapy for Polycystic Ovary Syndromes
: Systematic Review. J Korean Obstet
Gynecol. 2014;27(2):71-82.
on Polycystic Ovarian Syndrome. J
Korean Obstet Gynecol. 1997;10(1):
of Outpatients in Oriental Obstetric
& Gynecology Clinic of the Oriental
Hospital for 3 Years. J Korean Obstet
Gynecol. 2011;24(4):163-73.
Complaints of Outpatients Visiting
Seoul. J Korean Obstet Gynecol. 2017;
30(1):29-41.
of 106 Breast Cancer Patients Who
Received Oriental Medical Treatment.
:228-36.
in Female Infertility who Admitted
to Oriental Hospital. J Korean Obstet
Gynecol. 2010;23(3):184-91.
in Female Infertility Patients Admitted
to Korean Medicine Hospital. J Korean
Obstet Gynecol. 2013;26(2):120-37.
of Outpatients in Oriental Obstetric
& Gynecology Clinic of the Oriental
Hospital for 3 Years. J Korean
Obstet Gynecol. 2011;24(4):163-73.
Clinical Analysis of 104 Sanhupung
Patients that visited at an Oriental
Medicine Hospital. J Korean Obstet
Gynecol. 2010;23(3):192-204.
with Postpartum Disease at the Korean
Gynecology Clinic of Traditional Korean
Medicine Hospital. J Korean Obstet
Gynecol. 2018;31(3):61-78.
of Oriental Medicine Treatment for
Polycystic Ovarian Disease. J Korean
Obstet Gynecol. 2000;13(2):437-51.
PCOS Consensus Workshop Group.
Fertil Steril. 2004;81(1):19-25.
http://www.koreantk.com/ktkp2014/
dictionary/dictionary-view.page.
16. Stein IF, Leventhal ML. Amenorrhea
46
29(2):181-91.
Criteria for Polycystic Ovary Syndrome:
Towards a Rational Approach. In
Polycystic Ovary Syndrome. Dunaif
GR, eds. 1st ed. Boston:Blackwell
Scientific. 1992:377-84.
and PCOS Society Criteria for the
Polycystic Ovary Syndrome: The
Steril. 2009;91(2):456-88.
Is There an Asian Phenotype for
Polycystic Ovarian Syndrome? Best
Practice & Research Clinical Obstetrics
Effect of Integrated Medicine for
Polycystic Ovary Syndrome Subfertility
Meta-Analysis. J Korean Obstet
Moxibustion . Gyeonggido:Jipmoondang.
-acupuncture on Sameumgyo(SP-6)·
2003;16(2):76-86.
Donguibogamchulpansa. 2010:300-1,
310-1, 1750-1.
Korean Obstet Gynecol. 1998;11(1)
on Body Weight and Ovarian Reaction
in Obesity Mice. J Korean Obstet
Gynecol. 2003;16(2):68-75.
-tang on the Progression of the
Estradiol Valerate-induced Polycystic
Gynecol. 2010;23(2):1-19.
-tang on the Polycystic Ovaries Induced
by Estradiol Valerate in Rats. J
Korean Obstet Gynecol. 2002;15(2)
-tang on the Maturation of Follicles
and NGF Expression in Rats with
Estradiol Valerate-induced Polycystic
2011;24(2):52-67.
Gigantis Radix on Gene Expression
of Ovarian Tissue in Polycystic Ovary
Syndrome Rats. J Korean Obstet
Gynecol. 2011;24(3):28-47.
Rhizoma on Ovarian Tissue in
Polycystic Ovary Syndrome Rats. J
Korean Obstet Gynecol. 2012;25(2)
Spina on the Polycystic Ovary Induced
J Korean Obstet Gynecol Vol.32 No.1 February 2019
47
Korean Obstet Gynecol. 2010;23(2)
Rhizoma on Relevant Conditions of
Metabolic Syndrome in Rats with
Polycystic Ovary Syndrome. J Korean
Obstet Gynecol. 2011;24(4):20-30.
on the Estradiol Valerate-induced
Obstet Gynecol. 2008;21(3):60-74.
on the Maturation of Follicles and
NGF Expression in Rats with Estradiol
Valerate-induced Polycystic Ovaries.
:27-41.
-tang on the Progression of the
Estradiol Valerate-induced Polycystic
J Korean Obstet Gynecol. 2011;24(3)
:48-72.
-tang on the Estradiol Valerate-induced
Polycystic Ovary in Rats. J Korean
Obstet Gynecol. 2007;20(1):99-113.
-tang on the Estradiol Valerate-
induced Polycystic Ovaries in Rats.
J Korean Obstet Gynecol. 2008;21(2)
:1-16.
Shingihwanhapchangbudodam-tang
Obstet Gynecol. 2007;20(1):84-98.
for the One Case that Diagnosed
Polycystic Ovarian Disease. J Korean
Obstet Gynecol. 2014;27(3):151-7.
of 20 Amenorrhea or Oligomenorrhea
Patients due to Polycystic Ovarian
Syndrome. J Korean Obstet Gynecol.
2016;29(3):47-56.